Patient Safety Notices & Resources

Quality & Practice

Did you find what you're looking for?

If not, email us at


The Academy receives notices from the Centers for Disease Control (CDC), the Food and Drug Administration's (FDA) MedWatch program, and other sources when there is a patient safety announcement that could affect PM&R practices.

When an urgent public health alert occurs, the Academy will send an electronic message directly to its members. Be sure to update your Member Profile so the Academy has your current e-mail address on-file. The Academy encourages its members to stay in-tune with this important patient safety information, and has created an RSS feed so that all alerts posted on our website will be sent to you immediately.

Below is a chronologic list of notices that may be of interest to you or your practice. Click on the title of the notice to be taken to the reporting agency for more information.

To see all alerts from​ reporting agencies, click on the links below.

Pradaxa (dabigatran): Drug Safety Communication - Lower Risk for Stroke and Death, but Higher Risk for GI Bleeding Compared to Warfarin

May 13, 2014

Leave a comment